In the early days of UK roll out. When we started to hear news of clots happening. The actual numbers indicated Pfizer was seeing slightly more clots per dose. Still tiny tiny numbers of people effected. But AZ was the only one that faced the EU rejection from those results.
I am curious how and if that data changed as more doses were given.
thanks although I wonder why the mrna versions seem to avoid it.
In the early days of UK roll out. When we started to hear news of clots happening. The actual numbers indicated Pfizer was seeing slightly more clots per dose. Still tiny tiny numbers of people effected. But AZ was the only one that faced the EU rejection from those results.
I am curious how and if that data changed as more doses were given.